Advertisement

Development of an Individual Prevention Tool: The Breast Cancer Risk Profile

  • Alvaro Luis Ronco
  • Eduardo De Stéfani
Chapter

Abstract

In order to give personalized preventive recommendations, on a basis of ­country-specific research findings and putative risk and protective factors which are mostly modifiable, we developed an individual risk profile report oriented to lower the woman’s risk level of breast cancer as much as possible. The available data are requested through a thorough questionnaire on sociodemographics, family history of cancers, reproductive history, diet, lifestyle and occupation, completed with a detailed anthropometric assessment, which allows calculation of body composition and somatotype. Additional information is obtained from non-clinical tests as mammography and selected laboratory results. A series of 20 items – which includes family history of cancer; reproductive factors; intake of: red meat, white meat, dairy foods, oils and fats, high glycemic load foods, vegetables and fruits; alcohol consumption; physical activity; psychosocial stressors; metabolic disturbances; other medical factors; fat-to-muscle ratio; serum vitamin D level; urine 2:16 α-OH estrogens ratio; serum triglycerides/HDL ratio; fasting insulinemia, and mammographic density – is taken into account to compose a tailored risk profile, which enables us to give the patient a number of useful guidelines. Patients should undergo a follow-up during a minimum time of 1 year, with the aim of checking whether the expected changes are having place or not. Although generalizability of the proposal is limited in the case by populational features of Uruguayan women, it is feasible from a practical viewpoint, taking into account the necessary resources for its application.

Keywords

Mammographic Density Serum Vitamin Insulin Resistance Syndrome Dairy Food White Meat 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Dunn JE (1969) Epidemiology and possible identification of high-risk groups that could develop cancer of the breast. Cancer 23:775–780PubMedCrossRefGoogle Scholar
  2. 2.
    Fournier D, Kuttig H, Müller A et al (1977) Brustkrebsfrüherkennung: Kontrolle von Risikogruppen oder Massescreening – wer soll geröntgt werden? Med Welt 28:359–363PubMedGoogle Scholar
  3. 3.
    Soini I, Hakama M (1978) Failure of selective screening for breast cancer by combining risk factors. Int J Cancer 22:275–281PubMedCrossRefGoogle Scholar
  4. 4.
    Toti A, Piffanelli A, Pavanelli CN et al (1980) Possible indication of breast cancer risk through discriminant functions. Cancer 46(5):1280–1285PubMedCrossRefGoogle Scholar
  5. 5.
    Seidman H, Stellman SD, Mushinski MH (1982) A different perspective on breast cancer risk factors: some implications of the nonattributable risk. CA Cancer J Clin 32(5):301–313PubMedCrossRefGoogle Scholar
  6. 6.
    Schechter MT, Miller AB, Baines CJ et al (1986) Selection of women at high risk of breast cancer for initial screening. J Chron Dis 39(4):253–260PubMedCrossRefGoogle Scholar
  7. 7.
    Mettlin C (1994) The relationship of breast cancer epidemiology to screening recommendations. Cancer 74:228–230PubMedCrossRefGoogle Scholar
  8. 8.
    Torner J, Fernández Martínez I, Granell J et al (1996) Screening masivo versus screening selectivo. Rev Senologia y Patol Mam 10(1):31–43Google Scholar
  9. 9.
    Chart PL, Franssen E (1997) Management of women at increased risk for breast cancer: preliminary results from a new program. CMAJ 157(9):1235–1242PubMedGoogle Scholar
  10. 10.
    Gail MH, Brinton LA, Byar DP et al (1989) Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 81:1879–1886PubMedCrossRefGoogle Scholar
  11. 11.
    Costantino JP, Gail MH, Pee D et al (1999) Validation studies for models projecting the risk of invasive and total breast cancer incidence. J Natl Cancer Inst 91:1541–1548PubMedCrossRefGoogle Scholar
  12. 12.
    Djordjevic M, Vuletic L, Jovicevic-Bekic A et al (1994) Follow-up of risk groups for breast cancer 1990–2000. In: Sankaranarayanan R, Wahrendorf J, Demaret E (eds) Directory of on-going research in cancer epidemiology 1994, IARC Scientific Public. Nº 130. International Agency for Research on Cancer, Lyon, p 510 (abstract 1242)Google Scholar
  13. 13.
    Djordjevic M, Babic M, Drecun V et al (1999) Results of the questionnaired selective screening for the breast cancer. In: Proceedings of the I conference on screening and early detection of cancer, Development of a European Strategy, Vienna, Abstract 9006, p 39Google Scholar
  14. 14.
    Ronco AL (1998) Evaluation of classificatory capabilities of an artificial neural network in search of breast cancer risk populations: a pilot study, X International congress of breast diseases, Oporto, 31/V–4/VI, 1998, The Breast J 4(Suppl 1):S22. Abstract No 120Google Scholar
  15. 15.
    Ronco AL (1999) Discriminating breast cancer high-risk individuals with artificial neural networks: a novel approach to selective screenings. In: Proceedings of the I conference on screening and early detection of cancer, Development of a European Strategy, Vienna, 18–19 Nov 1999, Abstract 9030, p 51Google Scholar
  16. 16.
    Ronco AL (1999) Use of artificial neural networks in modeling associations of discriminant factors: towards an intelligent selective breast cancer screening. Artif Intell Med 16(3):299–309PubMedCrossRefGoogle Scholar
  17. 17.
    Ronco AL, De Stéfani E (1999) Role of classical and dietary discriminant factors for classification of breast cancer high-risk populations: a study with neural networks. Cancer Strategy 1:203–209Google Scholar
  18. 18.
    Ronco AL, De Stéfani E, Deneo-Pellegrini H (eds) (2008) Epidemiología Nutricional del Cáncer de Mama. Ed.de la Plaza, MontevideoGoogle Scholar
  19. 19.
    Ronco AL, De Stéfani E, Stoll M (2010) Hormonal and metabolic modulation through nutrition: towards a primary prevention of breast cancer. Breast 19:322–332PubMedCrossRefGoogle Scholar
  20. 20.
    Ronco AL, Maisonneuve J, Stoll M, et al (2010) The breast cancer risk profile report: development of a personalized preventive tool. XVI World congress on breast diseases, Valencia, 20–22 Oct 2010Google Scholar
  21. 21.
    Bradlow HL, Telang NT, Sepkovic DW et al (1996) 2-hydroxyestrone: the “good” estrogen. J Endocrinol 150(Suppl):S259–S265PubMedGoogle Scholar
  22. 22.
    Kabat GC, Jen Chang C, Sparano JA et al (1997) Urinary estrogen metabolites and breast cancer: a case-control study. Cancer Epidemiol Biomarkers Prev 6:505–509PubMedGoogle Scholar
  23. 23.
    Ho GH, Luo XW, Ji CY et al (1998) Urinary 2/16α-hydroxyestrone ratio: correlation with serum insulin-like growth factor binding protein-3 and a potential biomarker of breast cancer risk. Ann Acad Med Singapore 27:294–299PubMedGoogle Scholar
  24. 24.
    Coker AL, Crane MM, Sticca RP et al (1997) Re: ethnic differences in estrogen metabolism in healthy women. J Natl Cancer Inst 89:89PubMedCrossRefGoogle Scholar
  25. 25.
    Meilahn EN, De Stavola B, Allen DS et al (1998) Do urinary oestrogen metabolites predict breast cancer? Guernsey III cohort follow-up. Br J Cancer 78:1250–1255PubMedCrossRefGoogle Scholar
  26. 26.
    Muti P, Bradlow HL, Micheli A et al (2000) Estrogen metabolism and risk of breast cancer: a prospective study of the 2:16alpha-hydroxyestrone ratio in premenopausal and postmenopausal women. Epidemiology 11(6):635–640PubMedCrossRefGoogle Scholar
  27. 27.
    Cauley JA, Zmuda JM, Danielson ME et al (2003) Estrogen metabolites and the risk of breast cancer in older women. Epidemiology 14(6):740–744PubMedCrossRefGoogle Scholar
  28. 28.
    Campbell KL, Westerlind KC, Harber VJ et al (2005) Associations between aerobic fitness and estrogen metabolites in premenopausal women. Med Sci Sports Exerc 37(4):585–592PubMedCrossRefGoogle Scholar
  29. 29.
    Campbell KL, Westerlind KC, Harber VJ et al (2007) Effects of aerobic exercise training on estrogen metabolism in premenopausal women: a randomized controlled trial. Cancer Epidemiol Biomarkers Prev 16(4):731–739PubMedCrossRefGoogle Scholar
  30. 30.
    Westerlind KC, Williams NI (2007) Effect of energy deficiency on estrogen metabolism in premenopausal women. Med Sci Sports Exerc 39(7):1090–1097PubMedGoogle Scholar
  31. 31.
    Garland CF, Garland FC, Gorham ED et al (2006) The role of vitamin D in cancer prevention. Am J Public Health 96(2):252–261PubMedCrossRefGoogle Scholar
  32. 32.
    Cui Y, Rohan TE (2006) Vitamin D, calcium, and breast cancer risk: a review. Cancer Epidemiol Biomarkers Prev 15(8):1427–1437PubMedCrossRefGoogle Scholar
  33. 33.
    Gorham ED, Garland FC, Garland CF (1990) Sunlight and breast cancer incidence in the USSR. Int J Epidemiol 19(4):820–824PubMedCrossRefGoogle Scholar
  34. 34.
    Gorham ED, Garland CF, Garland FC (1989) Acid haze air pollution and breast and colon cancer mortality in 20 Canadian cities. Can Public Health 80:96–100Google Scholar
  35. 35.
    Garland FC, Garland CF, Gorham ED et al (1990) Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation. Prev Med 19:614–622PubMedCrossRefGoogle Scholar
  36. 36.
    Garland CF, Gorham ED, Mohr SB et al (2007) Vitamin D and prevention of breast cancer: pooled analysis. J Steroid Biochem Mol Biol 103(3–5):708–711PubMedCrossRefGoogle Scholar
  37. 37.
    Thomas MK, Lloyd-Jones DM, Thadhani RI et al (1998) Hypovitaminosis D in medical inpatients. N Engl J Med 338(12):777–783PubMedCrossRefGoogle Scholar
  38. 38.
    Mendoza B, Ronco AL (2001) Importancia de los niveles séricos de vitamina D-3. Tendencias 9(18):97–101Google Scholar
  39. 39.
    Mendoza B, Ronco AL, Mintegui G et al (2006) Serum vitamin D status among postmenopausal Uruguayan women. In: Proceedings of the international osteoporosis foundation world congress, Toronto, 2–6th June 2006, Abstract p704su, p S208Google Scholar
  40. 40.
    Mendoza BA, Ronco AL (2007) Vitamin D and breast cancer: a short review. Biomedicina 2(3):139–148Google Scholar
  41. 41.
    Stoll BA (1999) Western nutrition and the insulin resistance syndrome: a link to breast cancer. Eur J Clin Nutr 53(2):83–87PubMedCrossRefGoogle Scholar
  42. 42.
    Furberg AS, Veierod MB, Wilsgaard T (2004) Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk. J Natl Cancer Inst 96:1152–1160PubMedCrossRefGoogle Scholar
  43. 43.
    Sinagra D, Amato C, Scarpilta AM (2002) Metabolic syndrome and breast cancer risk. Eur Rev Med Pharmacol Sci 6:55–59PubMedGoogle Scholar
  44. 44.
    Kissebah AH, Vydelingum N, Murray R et al (1982) Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab 54:254–260PubMedCrossRefGoogle Scholar
  45. 45.
    International Agency for Research on Cancer (2002) Cancer preventive effects. In: Vainio H, Bianchini F (eds) Weight control and physical activity IARC. Handbooks of cancer prevention, vol 6. IARC Press, Lyon, pp 83–206Google Scholar
  46. 46.
    Arunabh S, Pollack S, Yeh J et al (2003) Body fat content and 25-hydroxyvitamin D levels in healthy women. J Clin Endocrinol Metab 88(1):157–161PubMedCrossRefGoogle Scholar
  47. 47.
    LeShan L (1966) An emotional life history pattern associated with neoplastic disease. Ann NY Acad Sci 125:780–793PubMedCrossRefGoogle Scholar
  48. 48.
    Hagnell O (1966) The premorbid personality of persons who develop cancer in a total population investigated in 1947 and 1957. Ann NY Acad Sci 125:846–855PubMedCrossRefGoogle Scholar
  49. 49.
    Fox BH (1995) The role of psychological factors in cancer incidence and prognosis. Oncology (Huntingt) 9(3):245–253Google Scholar
  50. 50.
    Protheroe D, Turvey K, Horgan K et al (1999) Stressful life events and difficulties and onset of breast cancer: case-control study. BMJ 319(7216):1015–1016Google Scholar
  51. 51.
    Price MA, Tennant CC, Smith RC et al (2001) The role of psychosocial factors in the development of breast carcinoma: part I. The cancer prone personality. Cancer 91(4):679–685PubMedCrossRefGoogle Scholar
  52. 52.
    Price MA, Tennant CC, Butow PN et al (2001) The role of psychosocial factors in the development of breast carcinoma: part II. Life event stressors, social support, defense style, and emotional control and their interactions. Cancer 91(4):686–697PubMedCrossRefGoogle Scholar
  53. 53.
    Elstad JI (1998) The psycho-social perspective on social inequalities in health. In: Bartley M, Blane D, Davey Smith G (eds) The sociology of health inequalities. Blackwell, Oxford, pp 39–58Google Scholar
  54. 54.
    Krieger N (2001) Glossary of social epidemiology. J Epidemiol Community Health 55:693–700PubMedCrossRefGoogle Scholar
  55. 55.
    Schell LM, Liebermann LS (1981) Noise stress and cancer. In: Bammer K, Newberry BH (eds) Stress and cancer. C.J.Hogrefe, TorontoGoogle Scholar
  56. 56.
    Greer S, Watson M (1985) Towards a psychobiological model of cancer: psychological considerations. Soc Sci Med 20(8):773–777PubMedCrossRefGoogle Scholar
  57. 57.
    Ronco AL, Silveira S, De Stéfani E et al (2007) Sociocultural and psychologic factors and breast cancer: a case-control study in Montevideo, Uruguay. Biomedicina 1(3):6–17 (in Spanish)Google Scholar
  58. 58.
    Hall IJ, Newman B, Millikan RC et al (2000) Body size and breast cancer risk in black women and white women. The Carolina Breast Cancer Study. Am J Epidemiol 151:754–764PubMedGoogle Scholar
  59. 59.
    Shu XO, Jin F, Dai Q et al (2001) Association of body size and fat distribution with risk of breast cancer among Chinese women. Int J Cancer 94:449–455PubMedCrossRefGoogle Scholar
  60. 60.
    Macinnis RJ, English DR, Gertig DM et al (2004) Body size and composition and risk of postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 13:2117–2125PubMedGoogle Scholar
  61. 61.
    Lahmann PH, Hoffmann K, Allen N et al (2004) Body size and breast cancer risk: findings from the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer 111:762–771PubMedCrossRefGoogle Scholar
  62. 62.
    Chow LW, Lui KL, Chan JC et al (2005) Association between body mass index and risk of formation of breast cancer in Chinese women. Asian J Surg 28:179–184PubMedCrossRefGoogle Scholar
  63. 63.
    Krebs EE, Taylor BC, Cauley JA et al (2006) Measures of adiposity and risk of breast cancer in older postmenopausal women. J Am Geriatr Soc 54:63–69PubMedCrossRefGoogle Scholar
  64. 64.
    Okobia MN, Bunker CH, Zmuda JM et al (2006) Anthropometry and breast cancer risk in Nigerian women. Breast J 12:462–466PubMedCrossRefGoogle Scholar
  65. 65.
    Wu AH, Yu MC, Tseng CC et al (2007) Body size, hormone therapy and risk of breast cancer in Asian-American women. Int J Cancer 120:844–852PubMedCrossRefGoogle Scholar
  66. 66.
    Ronco AL, Mendoza B, Varas X et al (2008) Somatotype and risk of breast cancer: a case-control study in Uruguay. Braz J Epidemiol 11(2):215–227CrossRefGoogle Scholar
  67. 67.
    Ronco AL, Boeing H, De Stéfani E et al (2009) A case-control study on fat to muscle ratio and risk of breast cancer. Nutr Cancer 61(4):466–474PubMedCrossRefGoogle Scholar
  68. 68.
    Ronco AL, De Stéfani E (2010) Interrelationships between body composition and somatotype and the risk of breast cancer. XVI World congress on breast diseases, Valencia, 20–22 Oct 2010Google Scholar
  69. 69.
    World Cancer Research Fund/American Institute for Cancer Research (2007) Food, nutrition, physical activity, and the prevention of cancer: a global perspective. American Institute for Cancer Research, Washington, DCGoogle Scholar
  70. 70.
    Ronco AL, De Stefani E, Boffetta P et al (2006) Food patterns and risk of breast cancer: a factor analysis study in Uruguay. Int J Cancer 19:1672–1678CrossRefGoogle Scholar
  71. 71.
    Carter JEL (2002) The Heath-Carter anthropometric somatotype – instruction manual. TeP and Rosscraft, SurreyGoogle Scholar
  72. 72.
    Lord RS, Bongiovanni B, Bralley JA (2002) Estrogen metabolism and the diet-cancer connection: rationale for assessing the ratio of urinary hydroxylated estrogen metabolites. Altern Med Rev 7(2):112–129PubMedGoogle Scholar
  73. 73.
    Klug I, Dressendorfer R, Strasburger C et al (2000) Cortisol and 17-hydroxyprogesterone levels in saliva of healthy neonates. normative data and relation to body mass index, arterial cord blood pH and time of sampling after birth. Biol Neonate 78:22–26PubMedCrossRefGoogle Scholar
  74. 74.
    Chen Z, Zheng W, Dunning LM et al (1999) Within person variability of the ratios of urinary 2-hydroxyestrone to 16alpha-hydroxyestrone in Caucasian women. Steroids 64:856–859PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2012

Authors and Affiliations

  1. 1.Department of Epidemiology and Scientific MethodsIUCLAEH School of MedicineMontevideoUruguay
  2. 2.School of Medicine Department of Pathology Epidemiology GroupUniversidad de la RepúblicaMontevideoUruguay

Personalised recommendations